Get the latest news on drug recalls, safety alerts, new therapies and other important updates.
November 19, 2019
The manufacturer of ranitidine, a drug used to treat ulcers and other conditions where reduction of gastric secretion and acid output is desirable, is recalling the medicine due to a contamination that may cause cancer.
November 19, 2019
The manufacturer of ranitidine, a drug used to treat ulcers and other conditions where reduction of gastric secretion and acid output is desirable, is recalling the medicine due to a contamination that may cause cancer.
November 19, 2019
The manufacturer of ranitidine, a drug used to treat ulcers and other conditions where reduction of gastric secretion and acid output is desirable, is recalling the medicine due to a contamination that may cause cancer.
October 14, 2019
The manufacturer of ranitidine, a drug used to treat ulcers and other conditions where reduction of gastric secretion and acid output is desirable, is recalling the medicine due to a contamination that may cause cancer.
September 26, 2019
The manufacturer of NATPARA, a drug used to treat hypocalcemia in patients with hypoparathyroidism, is issuing a recall of all doses on the market because of a potential issue.
January 21, 2019
The Food and Drug Administration (FDA) has issued a voluntary recall of select irbesartan-containing drugs due to an impurity used in the manufacturing of these medicines.
January 4, 2019
The Food and Drug Administration (FDA) has issued a voluntarily recall of select losartan containing drugs due to an impurity used in the manufacturing of these medicines.
November 20, 2018
The Food and Drug Administration (FDA) has issued a voluntary recall of select generic valsartan and valsartan containing drugs due to an impurity used in the manufacturing of these medicines.
August 6, 2018
Novartis and Sandoz Inc. have voluntarily recalled certain blister card packages distributed in the U.S.
June 1, 2017
The maker of Ventolin HFA Inhaler® has voluntarily recalled select lots from the U.S. marketplace. This recall was initiated due to a defect in certain lots of the inhaler that causes the product to deliver fewer doses than indicated.
June 1, 2017
The maker of EpiPen® and EpiPen Jr® Auto-Injectors has voluntarily recalled selected lots distributed in the U.S. and other markets. This recall was initiated due to reports of possible device malfunctions that could result in the devices failing to activate or requiring increased force to activate in an emergency or life-threatening situation.